TABLE 1.
Patient | Age | Sex | Location | Diagnosis | RNA-Seq | FISH |
---|---|---|---|---|---|---|
A1 | 58 | F | Breast, L | DFSP | COL6A3-PDGFD | PDGFD |
A2 | 29 | F | Breast, L | DFSP | COL6A3-PDGFD | PDGFD |
A3 | 36 | F | Breast, L | DFSP | COL6A3-PDGFD | PDGFD |
A4 | 22 | F | Breast, L | DFSP | PDGFD | |
A5 | 67 | M | Lung* | F-DFSP | COL1A1-PDGFB | |
A6 | 26 | F | Abdomen | F-DFSP | COL1A1-PDGFB | Negative |
A7 | 16 | M | Groin | DFSP | COL1A1-PDGFB | Negative |
A8 | 35 | M | Shoulder | DFSP | PDGFB | |
A9 | 23 | F | Shoulder | DFSP | PDGFB | |
A10 | 61 | F | Groin | DFSP | PDGFB | |
A11 | 49 | M | Neck | F-DFSP | PDGFB | |
A12 | 50 | F | Back | DFSP | PDGFB | |
A13 | 45 | F | Groin | DFSP | PDGFB | |
A14 | 28 | F | Back | DFSP | PDGFB | |
A15 | 32 | F | Foot | F-DFSP | PDGFB | |
A16 | 34 | F | Back | F-DFSP | PDGFB | |
A17 | 28 | F | Thigh | DFSP | PDGFB | |
A18 | 34 | M | Scalp | DFSP | PDGFB | |
A19 | 71 | F | Groin | F-DFSP | PDGFB | |
A20 | 74 | M | Thigh | F-DFSP | PDGFB | |
A21 | 20 | F | Hand | P-DFSP | PDGFB | |
A22 | 29 | M | Back | F-DFSP | PDGFB | |
A23 | 19 | M | Hand | F-DFSP | PDGFB | |
A24 | 44 | F | Abdomen | DFSP | COL1A1-PDGFB | |
A25 | 83 | F | Back | DFSP | COL1A1-PDGFB | |
A26 | 43 | F | Breast | DFSP | COL1A1-PDGFB | |
A27 | 69 | M | Thigh | DFSP | COL1A1-PDGFB | |
A28 | 43 | F | Scalp | DFSP | COL1A1-PDGFB | |
A29 | 56 | M | Chest | F-DFSP | COL1A1-PDGFB | |
A30 | 36 | F | Back | DFSP | COL1A1-PDGFB | |
A31 | 25 | M | Thigh | DFSP | COL1A1-PDGFB | |
A32 | 33 | M | Chest | DFSP | COL1A1-PDGFB | |
A33 | 50 | M | Back | DFSP | COL1A1-PDGFB | |
A34 | 47 | F | Thigh | DFSP | COL1A1-PDGFB | |
A35 | 61 | M | Chest | DFSP | COL1A1-PDGFB | |
A36 | 79 | M | Chest | F-DFSP | COL1A1-PDGFB | |
A37 | 39 | M | Chest | DFSP | COL1A1-PDGFB | |
A38 | 34 | M | Abdomen | DFSP | COL1A1-PDGFB | |
A39 | 39 | F | Arm | DFSP | COL1A1-PDGFB | |
A40 | 34 | M | Abdomen | DFSP | COL1A1-PDGFB | |
A41 | 35 | F | Shoulder | P-DFSP | COL1A1-PDGFB | |
A42 | 29 | F | Axilla | DFSP | COL1A1-PDGFB | |
A43 | 17 | F | Breast | DFSP | COL1A1-PDGFB | |
A44 | 37 | F | Abdomen | DFSP | COL1A1-PDGFB | |
A45 | 67 | F | Buttock | DFSP | COL1A1-PDGFB | |
A46 | 49 | M | Thigh | DFSP | COL1A1-PDGFB | |
A47 | 37 | F | Neck | DFSP | COL1A1-PDGFB | |
A48 | 41 | F | Groin | DFSP | COL1A1-PDGFB | |
A49 | 49 | M | Shoulder | F-DFSP | COL1A1-PDGFB | |
A50 | 61 | M | Abdomen | DFSP | COL1A1-PDGFB | |
A51 | 53 | M | Sacrum | DFSP | COL1A1-PDGFB | |
A52 | 53 | M | Buttock | F-DFSP | COL1A1-PDGFB | |
A53 | 35 | F | Arm | DFSP | COL1A1-PDGFB | |
A54 | 51 | M | Scalp | DFSP | COL1A1-PDGFB | |
A55 | 28 | F | Back | DFSP | COL1A1-PDGFB | |
A56 | 52 | F | Back | DFSP | COL1A1-PDGFB | |
A57 | 54 | F | Chest | DFSP | COL1A1-PDGFB | |
A58 | 70 | M | Arm | F-DFSP | COL1A1-PDGFB | |
A59 | 39 | F | Sacrum | DFSP | COL1A1-PDGFB | |
A60 | 35 | F | Abdomen | DFSP | PDGFB | |
A61 | 35 | M | Chest | DFSP | PDGFB | |
A62 | 26 | F | Hand | DFSP | PDGFB | |
A63 | 51 | F | Breast | F-DFSP | Negative | |
B1 | 51 | F | Breast | DFSP | PDGFD | |
B2 | 38 | F | Breast | DFSP | PDGFD | |
B3 | 40 | F | Breast | F-DFSP | PDGFB | |
B4 | 79 | F | Breast | DFSP | PDGFB | |
B5 | 31 | F | Breast | F-DFSP | PDGFB | |
B6 | 45 | F | Breast | DFSP | PDGFB | |
B7 | 48 | F | Chest wall | DFSP | PDGFB | |
B8 | 38 | F | Breast | DFSP | PDGFB | |
B9 | 44 | F | Breast | DFSP | PDGFB | |
B10 | 36 | F | Breast | DFSP | PDGFB | |
B11 | 40 | F | Breast | DFSP | PDGFB | |
B12 | 31 | F | Breast | DFSP | PDGFB | |
B13 | 26 | F | Breast | DFSP | PDGFB | |
B14 | 34 | F | Breast | DFSP | PDGFB | |
B15 | 36 | F | Chest wall | DFSP | Negative |
Cohort A: Prospective molecular testing of patients diagnosed with dermatofibrosarcoma protuberans over approximately 1 year. Cohort B: Retrospective molecular testing of patients diagnosed with dermatofibrosarcoma protuberans arising specifically on the breast or upper chest over approximately one decade. Novel variant highlighted in bold.
Abbreviations: DFSP, dermatofibrosarcoma protuberans; F, fibrosarcomatous; P, pigmented; F, female; L, left; M, male; FISH, fluorescence in situ hybridization.
Primary leg with lung metastasis.